2-benzofuran-1(3H)-one

We are 2-benzofuran-1(3H)-one CAS:87-41-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-benzofuran-1(3H)-one
CAS.NO:87-41-2
Synonyms:2-benzofuran-1(3H)-one
1-Isobenzofuranone
isobenzofuran-1-one
1(3H)-4,5,6,7-tetrachloroisobenzofuranone
3-oxo-1,3-dihydro-isobenzofuran
4,5,6,7-tetrachloro-1(3H)-isobenzofuranone
Phthalide
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 290.0±0.0 °C at 760 mmHg
Melting Point 71-74 °C(lit.)
Molecular Formula C8H6O2
Molecular Weight 134.132
Flash Point 124.8±22.2 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.585
 
Specification:
Appearance:White flake solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Kresoxim-methyl(CAS:143390-89-0).

2-benzofuran-1(3H)-one


Related News: Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added.Clorhidrato de (1S) -4,5-dimetoxi-1 – [(metilamino) metil] benzociclobutano CAS:866783-13-3 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.5-cloro-1-penteno CAS:928-50-7 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.906673-54-9 This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.

Related Products
Product Name
CBZ-valganciclovir View Details
Ferrous Sulfate Heptahydrate View Details
Tetramethylammonium chloride View Details
6-Hydroxy-2-naphthimidamide methanesulfonate salt manufacturer 2-Methoxy-4-methylpyridine manufacturer 6-Bromopicolinic acid manufacturer Methyl N-cyanoethanimideate manufacturer Tripeptide-10 citrulline manufacturer